Skip to content

Study of Central Response Characteristics of Ear Acupoint Pressing Needle Therapy for Insomnia in a High-Altitude Environment Based on fNIRS Technology.

Investigation into Central Response Characteristics of Ear Acupoint Pressing Needle Intervention for Insomnia in High-Altitude Environments Based on fNIRS Technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000004
Enrollment
Unknown
Registered
2026-01-04
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Sponsors

General Hospital of Western Theater Command of the People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Subjects eligible for inclusion in this study must meet all of the following criteria: (1) Reside in an area with an altitude =2500 meters; (2) Be between 18 and 60 years old; (3) Possess basic reading and writing skills and be able to complete questionnaires independently; (4) Voluntarily participate in this study and sign the informed consent; (5) Meet the diagnostic criteria for insomnia; (6) Be right-handed.

Exclusion criteria

Exclusion criteria: Any subject meeting any of the following criteria will be excluded: (1) Subjects diagnosed with insomnia in plain areas; (2) Patients with severe physical diseases or mental disorders; (3) Patients with severe anxiety or depression (SDS =73 points, SAS =70 points); (4) Subjects who have regularly taken sedative-hypnotic or other sleep aids, or antidepressant and anti-anxiety medications within the past month; (5) Subjects currently participating in other clinical trials for interventions targeting insomnia; (6) Other subjects deemed unsuitable for participation in the clinical trial by the investigators for any reason.

Design outcomes

Primary

MeasureTime frame
Changes in Central Response Characteristics Before and After Treatment - Functional Near-Infrared Spectroscopy (fNIRS);Primary efficacy evaluation - Pittsburgh Sleep Quality Index (PSQI) score;

Secondary

MeasureTime frame
Secondary efficacy assessment - Insomnia Severity Index (ISI) score;Secondary efficacy evaluation - Self-Rating Anxiety Scale (SAS) score;Secondary efficacy evaluation - Self-Rating Depression Scale (SDS) score;

Countries

China

Contacts

Public ContactWang Wenchun

General Hospital of Western Theater Command of the People's Liberation Army

wwc1977biology@163.com18908069418

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026